PortalPublikationenReport from the Kick-off Meeting of the Cochrane Skin Group ...

Report from the Kick-off Meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN)

Standard

Report from the Kick-off Meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN). / Schmitt, J; Deckert, S; Alam, M; Apfelbacher, C; Barbaric, J; Bauer, A; Chalmers, J; Chosidow, O; Delamere, F; Doney, E; Eleftheriadou, V; Grainge, M; Johannsen, L; Kottner, J; Le Cleach, L; Mayer, A; Pinart, M; Prescott, L; Prinsen, C A C; Ratib, S; Schlager, J G; Sharma, M; Thomas, K S; Weberschock, T; Weller, K; Werner, R N; Wild, T; Wilkes, S R; Williams, H C.

in: BRIT J DERMATOL, Jahrgang 174, Nr. 2, 02.2016, S. 287-295.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Schmitt, J, Deckert, S, Alam, M, Apfelbacher, C, Barbaric, J, Bauer, A, Chalmers, J, Chosidow, O, Delamere, F, Doney, E, Eleftheriadou, V, Grainge, M, Johannsen, L, Kottner, J, Le Cleach, L, Mayer, A, Pinart, M, Prescott, L, Prinsen, CAC, Ratib, S, Schlager, JG, Sharma, M, Thomas, KS, Weberschock, T, Weller, K, Werner, RN, Wild, T, Wilkes, SR & Williams, HC 2016, 'Report from the Kick-off Meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN)', BRIT J DERMATOL, Jg. 174, Nr. 2, S. 287-295. https://doi.org/10.1111/bjd.14337

APA

Schmitt, J., Deckert, S., Alam, M., Apfelbacher, C., Barbaric, J., Bauer, A., Chalmers, J., Chosidow, O., Delamere, F., Doney, E., Eleftheriadou, V., Grainge, M., Johannsen, L., Kottner, J., Le Cleach, L., Mayer, A., Pinart, M., Prescott, L., Prinsen, C. A. C., ... Williams, H. C. (2016). Report from the Kick-off Meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN). BRIT J DERMATOL, 174(2), 287-295. https://doi.org/10.1111/bjd.14337

Vancouver

Schmitt J, Deckert S, Alam M, Apfelbacher C, Barbaric J, Bauer A et al. Report from the Kick-off Meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN). BRIT J DERMATOL. 2016 Feb;174(2):287-295. https://doi.org/10.1111/bjd.14337

Bibtex

@article{9c3a98d580f2455b9287921fa47a50f0,
title = "Report from the Kick-off Meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN)",
abstract = "A major obstacle of evidence-based clinical decision making is the use of nonstandardized, partly untested outcome measurement instruments. Core Outcome Sets (COSs) are currently developed in different medical fields to standardize and improve the selection of outcomes and outcome measurement instruments in clinical trials, in order to pool results of trials or to allow indirect comparison between interventions. A COS is an agreed minimum set of outcomes that should be measured and reported in all clinical trials of a specific disease or trial population. The international, multidisciplinary Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN) aims to develop and implement COSs in dermatology, thus making trial evidence comparable and, herewith, more useful for clinical decision making. The inaugural meeting of CSG-COUSIN was held on 17-18 March 2015 in Dresden, Germany, as the exclusive theme of the Annual Cochrane Skin Group Meeting. In total, 29 individuals representing a broad mix of different stakeholder groups, professions, skills and perspectives attended. This report provides a description of existing COS initiatives in dermatology, highlights current methodological challenges in COS development, and presents the concept, aims and structure of CSG-COUSIN.",
keywords = "Clinical Trials as Topic, Congresses as Topic, Dermatology, Evidence-Based Medicine, Humans, International Cooperation, Interprofessional Relations, Outcome Assessment (Health Care), Quality Assurance, Health Care, Journal Article, Research Support, Non-U.S. Gov't",
author = "J Schmitt and S Deckert and M Alam and C Apfelbacher and J Barbaric and A Bauer and J Chalmers and O Chosidow and F Delamere and E Doney and V Eleftheriadou and M Grainge and L Johannsen and J Kottner and {Le Cleach}, L and A Mayer and M Pinart and L Prescott and Prinsen, {C A C} and S Ratib and Schlager, {J G} and M Sharma and Thomas, {K S} and T Weberschock and K Weller and Werner, {R N} and T Wild and Wilkes, {S R} and Williams, {H C}",
note = "{\textcopyright} 2016 British Association of Dermatologists.",
year = "2016",
month = feb,
doi = "10.1111/bjd.14337",
language = "English",
volume = "174",
pages = "287--295",
journal = "BRIT J DERMATOL",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Report from the Kick-off Meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN)

AU - Schmitt, J

AU - Deckert, S

AU - Alam, M

AU - Apfelbacher, C

AU - Barbaric, J

AU - Bauer, A

AU - Chalmers, J

AU - Chosidow, O

AU - Delamere, F

AU - Doney, E

AU - Eleftheriadou, V

AU - Grainge, M

AU - Johannsen, L

AU - Kottner, J

AU - Le Cleach, L

AU - Mayer, A

AU - Pinart, M

AU - Prescott, L

AU - Prinsen, C A C

AU - Ratib, S

AU - Schlager, J G

AU - Sharma, M

AU - Thomas, K S

AU - Weberschock, T

AU - Weller, K

AU - Werner, R N

AU - Wild, T

AU - Wilkes, S R

AU - Williams, H C

N1 - © 2016 British Association of Dermatologists.

PY - 2016/2

Y1 - 2016/2

N2 - A major obstacle of evidence-based clinical decision making is the use of nonstandardized, partly untested outcome measurement instruments. Core Outcome Sets (COSs) are currently developed in different medical fields to standardize and improve the selection of outcomes and outcome measurement instruments in clinical trials, in order to pool results of trials or to allow indirect comparison between interventions. A COS is an agreed minimum set of outcomes that should be measured and reported in all clinical trials of a specific disease or trial population. The international, multidisciplinary Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN) aims to develop and implement COSs in dermatology, thus making trial evidence comparable and, herewith, more useful for clinical decision making. The inaugural meeting of CSG-COUSIN was held on 17-18 March 2015 in Dresden, Germany, as the exclusive theme of the Annual Cochrane Skin Group Meeting. In total, 29 individuals representing a broad mix of different stakeholder groups, professions, skills and perspectives attended. This report provides a description of existing COS initiatives in dermatology, highlights current methodological challenges in COS development, and presents the concept, aims and structure of CSG-COUSIN.

AB - A major obstacle of evidence-based clinical decision making is the use of nonstandardized, partly untested outcome measurement instruments. Core Outcome Sets (COSs) are currently developed in different medical fields to standardize and improve the selection of outcomes and outcome measurement instruments in clinical trials, in order to pool results of trials or to allow indirect comparison between interventions. A COS is an agreed minimum set of outcomes that should be measured and reported in all clinical trials of a specific disease or trial population. The international, multidisciplinary Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN) aims to develop and implement COSs in dermatology, thus making trial evidence comparable and, herewith, more useful for clinical decision making. The inaugural meeting of CSG-COUSIN was held on 17-18 March 2015 in Dresden, Germany, as the exclusive theme of the Annual Cochrane Skin Group Meeting. In total, 29 individuals representing a broad mix of different stakeholder groups, professions, skills and perspectives attended. This report provides a description of existing COS initiatives in dermatology, highlights current methodological challenges in COS development, and presents the concept, aims and structure of CSG-COUSIN.

KW - Clinical Trials as Topic

KW - Congresses as Topic

KW - Dermatology

KW - Evidence-Based Medicine

KW - Humans

KW - International Cooperation

KW - Interprofessional Relations

KW - Outcome Assessment (Health Care)

KW - Quality Assurance, Health Care

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1111/bjd.14337

DO - 10.1111/bjd.14337

M3 - SCORING: Journal article

C2 - 26779929

VL - 174

SP - 287

EP - 295

JO - BRIT J DERMATOL

JF - BRIT J DERMATOL

SN - 0007-0963

IS - 2

ER -